EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Cytomegalovirus (CMV) T‐Cell Mediated Immunity in Children With CMV DNAemia After Allogeneic Hematopoietic Cell Transplantation

Varvara Probst iD, Christopher P Ouellette iD, Eunkyung Song iD

Transplant Infectious Disease · 2026

DOI: 10.1111/tid.70253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2026. Verfasst von Varvara Probst und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Pediatrics, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections, Cytomegalovirus, Immunity, Cellular. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytomegalovirus (CMV) is among the most common infectious complications following allogeneic hematopoietic cell transplantation (allo‐HCT). The CMV T‐cell immunity panel (CMV‐TCIP, Viracor) assesses CMV cell‐mediated immunity (CMV‐CMI); however, its utility among pediatric allo‐HCT recipients remains unknown.

Methods

A retrospective analysis (January 2020–January 2024) among pediatric (≤ 18 years) allo‐HCT recipients with CMV DNAemia and at least one CMV‐TCIP test was performed. A %CMV‐CD4 + or %CMV‐CD8 + IFN‐γ ≤ 0.2% was categorized as a poor response, whereas a result > 0.2% was classified as adequate. Clinically significant CMV infection (csCMVi) was defined as viral load (VL) ≥ 500 IU/mL. CMV‐TCIP results were compared to CMV VL and the development of csCMVi after allo‐HCT.

Results

Twenty‐seven CMV‐TCIP results from 10 allo‐HCT recipients were analyzed. The median age at transplant was 8.5 years (IQR 2.75–14.3), predominantly for hematologic malignancy (70%), and with high‐risk CMV serostatus (R+, 90%). At the time of CMV‐TCIP testing, subjects with a VL < 500 IU/mL had a higher %CMV‐CD4 + IFN‐γ compared to those with a VL ≥ 500 IU/mL (0.36 vs. 0.04, p = 0.02). Peak CMV VLs were lower in those with adequate CD4 + and CD8 + T‐cell responses than in those with poor CD4 + and CD8 + T‐cell responses. In those who received CMV viral‐specific T‐cells (CMV‐VST, n = 5), increased %CD4 + and %CD8 + IFN‐γ responses post‐infusion were observed with a concordant downward trend in VL.

Conclusions

Our results demonstrate that the development of CMV‐CMI (particularly CD4 + IFN‐γ > 0.2%) was observed with lower CMV VLs and may provide immunologic insights into pediatric allo‐HCT recipients receiving CMV‐VST.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationCytomegalovirus InfectionsCytomegalovirusImmunity, CellularT-LymphocytesHumansChildFemaleRetrospective StudiesChild, PreschoolMaleAdolescentTransplantation, HomologousViral LoadDNA, ViralCD8-Positive T-LymphocytesInterferon-gammaInfant

Stichwörter der Autor:innen

cell‐mediated immunitycytomegalovirushematopoietic cell transplantation

Substanzen

DNA, ViralInterferon-gamma

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Pediatrics, University of Florida, Gainesville, Florida, USA.
  • Host Defense Program, Division of Infectious Diseases, Department of Pediatrics, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio, USA.

ORCID-Profile: Varvara Probst, Christopher P Ouellette, Eunkyung Song

Zitieren

APA

Probst, V., Ouellette, C. P., & Song, E. (2026). Evaluation of Cytomegalovirus (CMV) T‐Cell Mediated Immunity in Children With CMV DNAemia After Allogeneic Hematopoietic Cell Transplantation. Transplant Infectious Disease. https://doi.org/10.1111/tid.70253

Vancouver

Probst V, Ouellette CP, Song E. Evaluation of Cytomegalovirus (CMV) T‐Cell Mediated Immunity in Children With CMV DNAemia After Allogeneic Hematopoietic Cell Transplantation. Transplant Infectious Disease. 2026. doi:10.1111/tid.70253

BibTeX
@article{Probst2026,
  author = {Probst, Varvara and Ouellette, Christopher P and Song, Eunkyung},
  title = {Evaluation of Cytomegalovirus (CMV) T‐Cell Mediated Immunity in Children With CMV DNAemia After Allogeneic Hematopoietic Cell Transplantation},
  journal = {Transplant Infectious Disease},
  year = {2026},
  doi = {10.1111/tid.70253}
}
Kostenlos starten →